Coronary embolism in a patient with mitral valve prosthesis: successful management with tirofiban and half-dose tissue-type plasminogen activator.
Atmaca
Yusuf
Y
Department of Cardiology, Ankara University Faculty of Medicine, 06530 Karakusunlar, Ankara, Turkey. yusufatmaca1@yahoo.com
Ozdol
Cagdas
C
Erol
Cetin
C
D003328:Coronary Thrombosis / Q000188:drug therapy* / Q000209:etiology; D004617:Embolism / Q000188:drug therapy* / Q000209:etiology; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery*; D000077466:Tirofiban; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D014443:Tyrosine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D014443:Tyrosine; D010959:Tissue Plasminogen Activator; D000077466:Tirofiban